|
Company:
|
AYTU BIOPHARMA, INC (AYTU)
|
|
Form Type:
|
10-Q/A
|
|
Filing Date:
|
5/14/2019
|
|
CIK:
|
0001385818
|
|
Address:
|
373 INVERNESS PARKWAY
SUITE 206
|
|
City, State, Zip:
|
ENGLEWOOD, Colorado 80112
|
|
Telephone:
|
(720) 437-6580
|
|
Fiscal Year:
|
06/30
|
|
|
|
|
|
Last Trade
|
Last Trade:
$4.14
|
Change:
0.03 (0.73%)
|
Trade Time:
04:00 PM EST
|
Market Cap:
$104.21M
|
|
|
|
|
|
|
Description of Business
|
|
We are a specialty pharmaceutical company focused on identifying, acquiring,
and commercializing novel products that address significant patient needs. We
have multiple FDA-approved products on the market, and we seek to build a
portfolio of novel therapeutics that serve large medical needs, across a range
of conditions, through our in-house commercial team. Our commercial
infrastructure consists of a U.S.-based specialty sales force and an
international distribution network with presence in approximately fifty
countries.
We currently are focused on commercialization of four products, (i) Natesto®, a
testosterone replacement therapy, or TRT, (ii) Tuzistra®XR, a codeine based
antitussive, (iii) ZolpiMistTM, a short-term insomnia treatment and (iv),
MiOXSYS®, a novel in vitro diagnostic system for male infertility assessment.
|
|
|
|